Key terms
About ADIL
Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson & William B. Stilley in November 2010 and is headquartered in Charlottesville, VA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ADIL news
Mar 04
10:50am ET
Biotech Alert: Searches spiking for these stocks today
Mar 01
11:04am ET
Biotech Alert: Searches spiking for these stocks today
Feb 28
9:30am ET
Adial Pharmaceuticals awarded new patent from USPTO
Feb 26
8:30am ET
Two new option listings and option delistings on February 26th
Feb 16
11:22am ET
Biotech Alert: Searches spiking for these stocks today
Feb 15
11:05am ET
Biotech Alert: Searches spiking for these stocks today
Feb 14
1:22pm ET
Adial sees patent award boosting partnering efforts, says Brookline
Jan 18
8:38am ET
Adial Pharmaceuticals appoints Goodman as Chief Operating Officer
Jan 12
4:54pm ET
Adial Pharmaceuticals files $100M mixed securities shelf
Dec 20
9:09am ET
Adial Pharmaceuticals receives final reimbursement payment from Adovate
No recent news articles are available for ADIL
No recent press releases are available for ADIL
ADIL Financials
Key terms
Ad Feedback
ADIL Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ADIL Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range